16:38 , Jul 18, 2019 |  BC Innovations  |  Distillery Therapeutics

Gossamer's CR3 agonist sensitizes pancreatic cancer to therapies

DISEASE CATEGORY: Cancer INDICATION: Pancreatic cancer Gossamer Bio Inc.'s CR3 agonist, GB1275, could sensitize pancreatic cancer to chemotherapy, radiation and immunotherapy. A team co-led by Rush University's Vineet Gupta, who co-founded Gossamer-acquired Adhaere Pharmaceuticals Inc.,...
14:05 , May 16, 2017 |  BC Innovations  |  Distillery Therapeutics

Autoimmune disease; infectious disease

INDICATION: Lupus; sepsis; influenza virus Patient sample, cell culture and mouse studies suggest agonizing CR3 could help treat lupus, sepsis and influenza. Lupus patients harboring loss-of-function SNPs on CR3 had higher serum levels of type...